Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 29, 2022BiomedicinesOpen Access

Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis

View Full Paper
Ask AI
Bookmark
Share

Authors

TPTheodoros Ioannis PapadimitriouACA. van CaamPKP.M. van der Kraan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Papadimitriou et al. (2022) studied this question.

synapsesocial.com/papers/6a200375d40b4a263065aecdhttps://doi.org/10.3390/biomedicines10020316
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1FOXP3+ Treg Cells and Gender Bias in Autoimmune Diseases2015 · 153 citations
  2. 2Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis2013 · 460 citations
  3. 3Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma2001 · 141 citations
  4. 4Mast Cell Restricted Mouse and Human Tryptase·Heparin Complexes Hinder Thrombin-induced Coagulation of Plasma and the Generation of Fibrin by Proteolytically Destroying Fibrinogen2012 · 55 citations
  5. 5Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity2000 · 321 citations